UMN Pharma, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From UMN Pharma, Inc.
Despite having multiple world-class pharma companies and innovative research, Japan is notably absent as a source of candidate vaccines for the coronavirus. The pandemic is again throwing into sharp relief past and present challenges around the country's vaccines sector.
Concern and skepticism about Russia's rapid vaccine roll out. Meanwhile Japan is latest to reach deal with Pfizer/BioNTech.
London university ready to launch clinical trials of vaccine based on self-amplifying RNA technology shortly.
Multiple vaccine and drug developers across the world report progress and partnerships amid volatility in their shares.
- Large Molecule